Eric Nghe
Psychiatric/Mental Health · Berkeley, CANPI 1417466368
Payments from drug & device makers
Across 132 payments — averaging $40.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$747
- Johnson & Johnson$740
- Teva Pharmaceuticals USA, Inc.$738
- AbbVie$542
- Otsuka America Pharmaceutical, Inc.$519
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$464
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,341100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 25 | $747 |
| Johnson & Johnson | 12 | $740 |
| Teva Pharmaceuticals USA, Inc. | 6 | $738 |
| AbbVie | 18 | $542 |
| Otsuka America Pharmaceutical, Inc. | 15 | $519 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $464 |
| Lundbeck LLC | 14 | $330 |
| Biogen | 2 | $217 |
| Vanda Pharmaceuticals Inc. | 7 | $205 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| AMAG Pharmaceuticals, Inc. | 1 | $125 |
| Abbott | 2 | $114 |
| Boehringer Ingelheim | 1 | $99 |
| Gen-probe Sales & Service, Inc. | 1 | $86 |
| Janssen Scientific Affairs, LLC | 1 | $85 |
| Alkermes, Inc. | 3 | $80 |
| Indivior Inc. | 3 | $55 |
| Ironshore Pharmaceuticals Inc. | 2 | $41 |
| Tempus AI, Inc | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UZEDY$370
- REXULTI$363
- INVEGA SUSTENNA$355
- CAPLYTA$248
- Austedo XR$246
- INVEGA TRINZA$238
- Auvelity$231
- Fanapt$125
- NURTEC ODT$125
- VRAYLAR$125
- FERAHEME$125
- AUSTEDO$122
- Zurzuvae$122
How this compares
$5,353 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paxlovid (Eua)Nirmatrelvir/Ritonavir | 12 | $204 |
| Lamotrigine | 11 | $97 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Berkeley
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.